MediPal Holdings's latest marketcap:
As of 08/12/2025, MediPal Holdings's market capitalization has reached $3.61 B. According to our data, MediPal Holdings is the 4328th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 3.61 B |
Revenue (ttm) | 25.08 B |
Net Income (ttm) | 276.4 M |
Shares Out | 206.26 M |
EPS (ttm) | 1.33 |
Forward PE | 14.70 |
Ex-Dividend Date | 09/29/2025 |
Earnings Date | 08/05/2025 |
MediPal Holdings's yearly market capitalization.
Date | Market Cap(¥) | Market Cap(USD) | Change (%) | Global Rank |
---|---|---|---|---|
08/12/2025 | ¥532.98 B | $3.61 B | 7.67% | 4328 |
12/30/2024 | ¥495.03 B | $3.15 B | 2.54% | 4203 |
12/29/2023 | ¥482.78 B | $3.42 B | 32.07% | 3878 |
12/30/2022 | ¥365.54 B | $2.79 B | -19.21% | 4255 |
12/30/2021 | ¥452.47 B | $3.93 B | 11.2% | 3898 |
12/30/2020 | ¥406.91 B | $3.94 B | -19.69% | 3413 |
12/30/2019 | ¥506.64 B | $4.67 B | -3.29% | 2497 |
12/28/2018 | ¥523.91 B | $4.78 B | 5.55% | 2098 |
12/29/2017 | ¥496.38 B | $4.4 B | 18.94% | 2579 |
12/30/2016 | ¥417.33 B | $3.57 B | -11.14% | 2541 |
Company Profile
Company Overview
Medipal Holdings Corporation operates as a leading prescription pharmaceutical wholesaler in Japan, with a diverse portfolio of healthcare and related services.
Core Business Activities
- Pharmaceutical Wholesale: Procures and distributes healthcare products, including medical equipment, diagnostic reagents, and orphan drugs.
- Contract Services: Provides PMS (Post-Marketing Surveillance) services for manufacturers and engages in epidemiological and clinical studies.
- Diverse Product Distribution: Handles cosmetics, daily necessities, OTC pharmaceuticals, animal health products, and livestock feed additives.
- Healthcare Support Services: Offers medical database creation, insurance agency services, cleaning management, and logistics operations.
- Specialty Pharmaceuticals: Distributes niche medical products and provides medical administrative outsourcing.
Key Client Segments
The company serves a broad range of clients, including:
- Hospitals, clinics, and dispensing pharmacies
- Drugstores, supermarkets, and convenience stores
- Animal hospitals and livestock businesses
- Processed food manufacturers
Corporate Background
Originally founded in 1898 as Mediceo Paltac Holdings Co., Ltd., the company rebranded as Medipal Holdings Corporation in October 2009. Headquartered in Tokyo, Japan, it continues to expand its footprint in the healthcare supply chain.
Frequently Asked Questions
-
What is MediPal Holdings's (TYO-7459) current market cap?As of 08/12/2025, MediPal Holdings (including the parent company, if applicable) has an estimated market capitalization of $3.61 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does MediPal Holdings (TYO-7459) rank globally by market cap?MediPal Holdings global market capitalization ranking is approximately 4328 as of 08/12/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.